Trial Profile
Planned phase I study of an intravenous formulation of AFN 1252
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Mar 2013
Price :
$35
*
At a glance
- Drugs Debio 1452 (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions
- 26 Mar 2013 New trial record